Classification Term: 170692

Dipeptides (ontology term: 87eba020f2f3f9c5e6c6fa8c0ab07e37)

found 238 associated metabolites at sub_class metabolite taxonomy ontology rank level.

Child Taxonomies: There is no child term of current ontology term.

Ophthalmic acid

(2S)-2-amino-4-{[(1S)-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}butanoic acid

Ophthalmic acid, also known as ophthalmate, belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Ophthalmic acid is a very strong basic compound (based on its pKa). Ophthalmic acid is an L-glutamine derivative in which L-glutamine is substituted by a 1--1-oxobutan-2-yl at the terminal amino nitrogen atom. Ophthalmic acid is an analogue of glutathione isolated from crystalline lens. Ophthalmic acid is an analogue of glutathione isolated from crystalline lens. [HMDB]

Gliotoxin

10H-3,10a-Epidithiopyrazino(1,2-a)indole-1,4-dione, 2,3,5a,6-hydroxy-3- (hydroxymethyl)-2-methyl-, (3R-(3-alpha,5a-beta,6-beta,10a-alpha))-

C13H14N2O4S2 (326.0395)

Gliotoxin is a pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring; mycotoxin produced by several species of fungi. It has a role as a mycotoxin, an immunosuppressive agent, an EC 2.5.1.58 (protein farnesyltransferase) inhibitor, a proteasome inhibitor and an antifungal agent. It is an organic disulfide, a pyrazinoindole, an organic heterotetracyclic compound and a dipeptide. Gliotoxin is a natural product found in Streptomyces, Aspergillus cejpii, and other organisms with data available. Gliotoxin is a sulfur-containing antibiotic produced by several species of fungi, some of which are pathogens of humans such as Aspergillus, and also by species of Trichoderma, and Penicillium. Gliotoxin possesses immunosuppressive properties as it may suppress and cause apoptosis in certain types of cells of the immune system, including neutrophils, eosinophils, granulocytes, macrophages, and thymocytes. (L1941) A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent. A pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring; mycotoxin produced by several species of fungi. D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins C308 - Immunotherapeutic Agent > C574 - Immunosuppressant

Tryprostatin A

(3S-trans)-Hexahydro-3-[[6-methoxy-2-(3-methyl-2-butenyl)-1H-indol-3-yl]methyl]-pyrrolo[1,2-a]pyrazine-1,4-dione

C22H27N3O3 (381.2052)

A cyclic dipeptide that is brevianamide F (cyclo-L-Trp-L-Pro) substituted at positions 2 and 6 on the indole ring by prenyl and methoxy groups respectively.

Alanylproline

(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carboxylic acid

C8H14N2O3 (186.1004)

Alanylproline is a dipeptide composed of alanine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Leucylproline

(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)

Leucylproline is a dipeptide composed of leucine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411). A dipeptide found in urine (PMID: 3782411). This is a proteolytic breakdown product of larger proteins. [HMDB]

Valylproline

(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C10H18N2O3 (214.1317)

Valylproline is a dipeptide composed of valine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Prolylproline

(2S)-1-[(2S)-pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid

C10H16N2O3 (212.1161)

Prolylproline is a dipeptide composed of proline and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411).

Isoleucylproline

(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)

Isoleucylproline is a dipeptide composed of isoleucine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411).

Glutamylproline

(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C10H16N2O5 (244.1059)

Glutamylproline is a dipeptide composed of glutamate and proline, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylproline is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

N-carbamoylglutamic Acid

2-[(C-hydroxycarbonimidoyl)amino]pentanedioic acid

C6H10N2O5 (190.059)

N-carbamoylglutamic Acid, also known as N-Carbamoylglutamate, is classified as a glutamic acid or a Glutamic acid derivative. Glutamic acids are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-carbamoylglutamic Acid is considered to be soluble (in water) and acidic

Arphamenine B

5-amino-8-carbamimidamido-2-[(4-hydroxyphenyl)methyl]-4-oxooctanoic acid

C16H24N4O4 (336.1797)

Gliotoxin

7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5-diene-10,14-dione

C13H14N2O4S2 (326.0395)

beta-Alanyl-L-histidine

2-[(3-amino-1-hydroxypropylidene)amino]-3-(1H-imidazol-5-yl)propanoic acid

C9H14N4O3 (226.1066)

Phosphoglucomutase, also known as rnase, pancreatic or pancreatic rnase, is a member of the class of compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. Phosphoglucomutase is soluble (in water) and a weakly acidic compound (based on its pKa). Phosphoglucomutase can be found in soy bean, which makes phosphoglucomutase a potential biomarker for the consumption of this food product. Phosphoglucomutase (EC 5.4.2.2) is an enzyme that transfers a phosphate group on an α-D-glucose monomer from the 1 to the 6 position in the forward direction or the 6 to the 1 position in the reverse direction .

ophthalmic acid

L-gamma-Glutamyl-L-alpha-aminobutyrylglycine

C11H19N3O6 (289.1274)

A L-glutamine derivative that is L-glutamine substituted by a 1-[(carboxymethyl)amino]-1-oxobutan-2-yl at the terminal amino nitrogen atom. MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; JCMUOFQHZLPHQP-BQBZGAKWSA-N_STSL_0170_Ophthalmic acid_0500fmol_180425_S2_LC02_MS02_88; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I.

Ile-pro

L-Isoleucyl-L-proline

C11H20N2O3 (228.1474)

A dipeptide formed from L-isoleucine and L-proline residues.

Pro-pro

L-Prolyl-L-proline

C10H16N2O3 (212.1161)

A dipeptide formed from two L-proline residues.

p-Hydroxyhippuric Acid

2-[(4-Hydroxyphenyl)formamido]acetic acid

C9H9NO4 (195.0532)

An N-acylglycine that is the 4-hydroxy derivative of hippuric acid.

Ala-pro

2-(pyrrolidin-2-ylformamido)propanoic acid

C8H14N2O3 (186.1004)

A dipeptide composed of L-alanine and L-proline joined by a peptide linkage.

Val-pro

3-methyl-2-(pyrrolidin-2-ylformamido)butanoic acid

C10H18N2O3 (214.1317)

A dipeptide formed from L-valine and L-proline residues.

Glu-pro

(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C10H16N2O5 (244.1059)

A dipeptide composed of L-glutamic acid and L-proline joined by a peptide linkage.

Leu-pro

C11H20N2O3 (228.1474)

A dipeptide formed from L-leucine and L-proline residues.

(2s)-5-carbamimidamido-2-[2-(6-hydroxy-1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

C16H19N5O5 (361.1386)

(2s)-2-[(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-(3h-imidazol-4-yl)propanoic acid

C11H17N5O4 (283.128)

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-3-hydroxypropanoic acid

C8H16N2O4S (236.0831)

(2s)-2-{[hydroxy((2s)-pyrrolidin-2-yl)methylidene]amino}-n-(c-hydroxycarbonimidoylmethyl)-4-methylpentanimidic acid

C13H24N4O3 (284.1848)

2-[(3-amino-1-hydroxy-3-methylbutylidene)amino]-3-phenylpropanoic acid

C14H20N2O3 (264.1474)

(2s,3z)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-5-carbamimidamido-1-hydroxypentylidene]amino}-5-phosphonopent-3-enoic acid

C17H33N6O7P (464.2148)

methyl (2s)-2-(carbamoylformamido)-3-phenylpropanoate

C12H14N2O4 (250.0954)

(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy((2s)-pyrrolidin-2-yl)methylidene]amino}-3-(1h-indol-3-yl)propylidene]amino}-4-methylpentanimidic acid

C22H31N5O3 (413.2427)

(2s)-2-{[(2r)-2-{[(2r)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C23H26N4O4 (422.1954)

(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2s,3s,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C23H34N3O10P (543.1982)

(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C23H34N3O10P (543.1982)

(2s)-2-{n-[(s)-(2-imino-1,3-diazinan-4-yl)({[(1s)-3-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl})methyl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid

(2s)-2-{n-[(s)-(2-imino-1,3-diazinan-4-yl)({[(1s)-3-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl})methyl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid

C31H41N7O6 (607.3118)

(2r,5s)-5-amino-8-carbamimidamido-2-[(4-hydroxyphenyl)methyl]-4-oxooctanoic acid

C16H24N4O4 (336.1797)

(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C23H34N3O10P (543.1982)

(1s,7s,8s,11s)-11-(hydroxymethyl)-12-methyl-10,13-dioxo-14-thia-9,12-diazatetracyclo[9.2.1.0¹,⁹.0³,⁸]tetradeca-3,5-dien-7-yl acetate

C15H16N2O5S (336.078)

1-hydroxy-3-{[2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H25N3O2 (351.1947)

(2s)-2-{[(2s)-2-{[(2s)-1,3-dihydroxy-2-{[(2s)-1-hydroxy-2-(1h-pyrrol-2-ylformamido)butylidene]amino}propylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}butanoic acid

C25H33N5O7 (515.238)

(2s)-2-{[(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-1-hydroxy-3-sulfanylpropylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

(2s)-2-{[(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-1-hydroxy-3-sulfanylpropylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

C24H30N8O6S (558.2009)

2-{2-[(1-hydroxyethylidene)amino]-n,3-dimethylpentanamido}-3-phenylpropanoic acid

C18H26N2O4 (334.1892)

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C14H17N3O3 (275.127)

methyl 2-(carbamoylformamido)-3-phenylpropanoate

C12H14N2O4 (250.0954)

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C17H23N3O7S (413.1257)

2-[(4-hydroxyphenyl)formamido]pentanedioic acid

C12H13NO6 (267.0743)

(2s)-3-acetyl-2-aminopentanedioic acid; oxindole

C15H18N2O6 (322.1165)

(2r)-2-amino-3-{[(1z)-1-(hydroxyimino)-2-(1h-indol-3-yl)ethyl]sulfanyl}propanoic acid

C13H15N3O3S (293.0834)

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-5-({[(2r,3s)-3-[(2s)-butan-2-yl]-4-oxooxetan-2-yl](hydroxy)methylidene}amino)pentanoic acid

C16H27N3O6 (357.19)

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C15H22N2O4 (294.1579)

2-{2-[1-(carboxymethylcarbamoyl)ethylidene]hydrazin-1-yl}benzoic acid

C12H13N3O5 (279.0855)

(2s)-2-({[(2s)-1-[(2s)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-4-methylpentanoic acid

C16H29N3O4 (327.2158)

(1r,7s,8s,11r)-11-(hydroxymethyl)-17-methyl-10,16-dioxo-12,13,14,15-tetrathia-9,17-diazatetracyclo[9.4.2.0¹,⁹.0³,⁸]heptadeca-3,5-dien-7-yl acetate

C15H16N2O5S4 (431.9942)

(2r)-2-[(4-bromo-1h-pyrrol-2-yl)formamido]-6-carbamimidamidohexanoic acid

C12H18BrN5O3 (359.0593)

3-{[1-carboxy-2-(3h-imidazol-4-yl)ethyl]amino}-2-{[1-hydroxy-3-(3h-imidazol-4-yl)-2-(methylamino)propylidene]amino}butanoic acid

C17H25N7O5 (407.1917)

(2s)-2-[(4-bromo-1h-pyrrol-2-yl)formamido]-3-[(4s)-4-methyl-3,5-dihydroimidazol-4-yl]propanoic acid

C12H15BrN4O3 (342.0327)

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}propanoic acid

C23H26N4O4 (422.1954)

(2s)-2-[(2s)-2-{[(2s)-1,2-dihydroxy-3-methylbutylidene]amino}-n,3-dimethylbutanamido]-4-methylpentanoic acid

C17H32N2O5 (344.2311)

(2s,5r)-5-amino-8-carbamimidamido-2-[(4-hydroxyphenyl)methyl]-4-oxooctanoic acid

C16H24N4O4 (336.1797)

(2s)-2-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}butanedioic acid

C14H14N2O5 (290.0903)

(2s)-2-amino-6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}hexanoic acid

C16H21N3O3 (303.1583)

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-3-phenylpropanoic acid

C20H21N3O3 (351.1583)

(2s)-2-{[(2s,3s)-2-amino-1-hydroxy-3-methylpentylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

C12H20N4O3 (268.1535)

(2r)-4-[(1e)-2-{[(1s)-1-carboxy-4-hydroxybutyl]amino}ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

C14H18N2O7 (326.1114)

(2s)-2-{[(3-carboxypropyl)-c-hydroxycarbonimidoyl]amino}-4-(methylsulfanyl)butanoic acid

C10H18N2O5S (278.0936)

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C12H16N2O4 (252.111)

5-carbamimidamido-2-[(4-hydroxyphenyl)formamido]pentanoic acid

C13H18N4O4 (294.1328)

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}butanedioic acid

C19H27N3O6 (393.19)

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)

4,5-diamino-2-hydroxy-n-[1-(c-hydroxycarbonimidoyl)-3-methylbutyl]pentanimidic acid

C11H24N4O3 (260.1848)

(2s)-5-hydroxy-n-[(2s)-1-[(2s)-2-(c-hydroxycarbonimidoyl)pyrrolidin-1-yl]-3-(3h-imidazol-4-yl)-1-oxopropan-2-yl]-3,4-dihydro-2h-pyrrole-2-carboximidic acid

C16H22N6O4 (362.1702)

2-[(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene)amino]-3-methylbutanoic acid

C25H30N4O5 (466.2216)

(3s)-3-amino-3-{[(1s)-1-carboxy-2-(3h-imidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}propanoic acid

C10H14N4O5 (270.0964)

(3r)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-{[(1s)-1-carboxy-2-(3h-imidazol-4-yl)ethyl]amino}butanoic acid

C14H22N6O6 (370.1601)

(2s,3s)-2-[(2-amino-1-hydroxyethylidene)amino]-3-methylpentanoic acid

C8H16N2O3 (188.1161)

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-3-methylbutanoic acid

C25H30N4O5 (466.2216)

2-[(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]amino}-1-hydroxypropylidene)amino]benzoic acid

C15H19N3O6 (337.1274)

(2s)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C13H18N2O5 (282.1216)

(2s)-3-acetyl-2-aminopentanedioic acid; indole

C15H18N2O5 (306.1216)

2-amino-4-{[2-(benzylsulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid

C15H20N2O5S (340.1093)

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C17H23N3O7S (413.1257)

(3s)-3-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-{[(1s)-1-carboxy-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}propanoic acid

C19H27N3O7 (409.1849)

(2s)-2-amino-n-[(2s)-1-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-(1h-indol-3-yl)propanoyl]oxy}-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-3-methylbutanimidic acid

C32H40N6O5 (588.306)

{[(2s)-1-hydroxy-2-{[(2s)-1-hydroxy-2-{[hydroxy((2s)-pyrrolidin-2-yl)methylidene]amino}-3-(1h-indol-3-yl)propylidene]amino}-3-methylbutylidene]amino}acetic acid

C23H31N5O5 (457.2325)

(2s)-2-{[(2s)-2-amino-1,3-dihydroxypropylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

C9H14N4O4 (242.1015)

(2s)-2-({[(2s)-1-[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-hydroxypropanoic acid

C16H26N6O8 (430.1812)

(2s)-2-{[(3-carboxypropyl)-c-hydroxycarbonimidoyl]amino}-4-methylpentanoic acid

C11H20N2O5 (260.1372)

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C14H20N2O4 (280.1423)

(3r)-3-{[(2r,3s,4s,5r)-5-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1,2,3,4,6-pentahydroxyhexylidene]amino}-3-phenylpropanoic acid

C21H33N3O8 (455.2268)

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-4-methylpentanoic acid

C15H22N2O3 (278.163)

2-({2-[(1,3-dihydroxy-2-{[1-hydroxy-2-(1h-pyrrol-2-ylformamido)butylidene]amino}propylidene)amino]-1-hydroxy-3-phenylpropylidene}amino)butanoic acid

C25H33N5O7 (515.238)

(2s)-1-[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)

(1r,13s,16s,22s)-1-hydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-8-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁴,⁹.0¹⁴,²².0¹⁶,²⁰]tricosa-2,4(9),5,10-tetraene-15,21-dione

C26H31N3O4 (449.2314)

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-4-(methylsulfanyl)butanoic acid

C11H22N2O3S (262.1351)

(2r)-2-[(1-hydroxyethylidene)amino]-3-phenylpropanoic acid

C11H13NO3 (207.0895)

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-3-methylbutanoic acid

C14H20N2O3 (264.1474)

(2s,3s)-2-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoic acid

C15H22N2O4 (294.1579)

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C17H23N3O3 (317.1739)

(2r)-5-carbamimidamido-2-{[4-(1h-indole-3-carbonyloxy)phenyl]formamido}pentanoic acid

C22H23N5O5 (437.1699)

(2s)-2-[(2-amino-1-hydroxyethylidene)amino]-4-methylpentanoic acid

C8H16N2O3 (188.1161)

(10-hydroxydec-8-en-2,4,6-triynamido)acetic acid

C12H9NO4 (231.0532)

(2s)-2-{[(2s)-2-{[(2r)-2-[(2-amino-1-hydroxyethylidene)amino]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene]amino}butanedioic acid

C18H24N4O7 (408.1645)

(3s)-2-acetyl-3-aminobutanedioic acid; indole

C14H16N2O5 (292.1059)

(3s,9ar)-3-benzyl-1-hydroxy-3h,6h,7h,8h,9h,9ah-pyrido[1,2-a]pyrazin-4-one

C15H18N2O2 (258.1368)

(2s)-2-{[(3r)-3,4-dicarbamimidamido-1-hydroxybutylidene]amino}-3-(3,4-dihydroxyphenyl)propanoic acid

C15H23N7O5 (381.1761)

(2s)-2-{[(2s,3s)-1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}pentylidene]amino}butanedioic acid

C16H28N2O10 (408.1744)

(2s)-1-[(2s)-2-amino-4-methylpentanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

C11H20N2O4 (244.1423)

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-3-methylbutanoic acid

C10H20N2O3S (248.1195)

(3s,8as)-1-hydroxy-3-{[6-hydroxy-2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H25N3O3 (367.1896)

[(2-amino-1-hydroxyethylidene)amino]acetic acid

C4H8N2O3 (132.0535)

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-hydroxypropanoic acid

C9H18N2O4 (218.1267)

(2s,3r)-2-{[(2s)-2-amino-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-3-hydroxybutanoic acid

C9H18N2O4S (250.0987)

(2s)-2-amino-4-{[(1s)-1-carboxy-2-(3h-imidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C11H16N4O5 (284.1121)

carbamoyl aspartic acid

C5H8N2O5 (176.0433)

(2r)-2-[(isopropylsulfanyl)amino]-3-sulfanylpropanoic acid

C6H13NO2S2 (195.0388)

(3s)-3-amino-3-{[(1s)-1-carboxy-2-hydroxyethyl]-c-hydroxycarbonimidoyl}propanoic acid

C7H12N2O6 (220.0695)

(2s,3s)-2-{[(3-carboxypropyl)-c-hydroxycarbonimidoyl]amino}-3-methylpentanoic acid

C11H20N2O5 (260.1372)

(2s,3s)-2-{[(2s)-2-amino-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-3-methylpentanoic acid

C11H22N2O3S (262.1351)

(2s)-6-amino-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}hexanoic acid

C15H23N3O3 (293.1739)

(1r,7s,8s,11r)-7-hydroxy-11-(hydroxymethyl)-17-methyl-12,13,14,15-tetrathia-9,17-diazatetracyclo[9.4.2.0¹,⁹.0³,⁸]heptadeca-3,5-diene-10,16-dione

C13H14N2O4S4 (389.9836)

(2r)-2-[(4-bromo-1h-pyrrol-2-yl)formamido]-3-[(4s)-4-methyl-3,5-dihydroimidazol-4-yl]propanoic acid

C12H15BrN4O3 (342.0327)

2-[(4-bromo-1h-pyrrol-2-yl)formamido]-3-(4-methyl-3,5-dihydroimidazol-4-yl)propanoic acid

C12H15BrN4O3 (342.0327)

7-hydroxy-11-(hydroxymethyl)-16-methyl-12,13,14-trithia-9,16-diazatetracyclo[9.3.2.0¹,⁹.0³,⁸]hexadeca-3,5-diene-10,15-dione

C13H14N2O4S3 (358.0116)

(1r,7s,8r,11r)-7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5-diene-10,14-dione

C13H14N2O4S2 (326.0395)

(2s)-2-[(2-amino-1-hydroxyethylidene)amino]-3-methylbutanoic acid

C7H14N2O3 (174.1004)

(2s)-1-[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}propanoyl]pyrrolidine-2-carboxylic acid

C11H19N3O4 (257.1375)

{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxypropylidene]amino}acetic acid

C11H21N3O4 (259.1532)

(2s,3r)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-3-hydroxybutanoic acid

C13H18N2O4 (266.1267)

(3s,8as)-1-hydroxy-3-{[2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H25N3O2 (351.1947)

(2s)-2-aminopropanoyl (2s)-2-amino-3-[(1r,6r)-5-oxo-7-oxabicyclo[4.1.0]heptan-2-yl]propanoate

C12H18N2O5 (270.1216)

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-3-carboxy-1-hydroxypropylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-3-methylbutanoic acid

C31H36N6O7 (604.2645)

2-({2-[(2-amino-1-hydroxypropylidene)amino]-3-carboxy-1-hydroxypropylidene}amino)-5-phosphonopent-3-enoic acid

C12H20N3O9P (381.0937)

(2s)-2-[(2-amino-1-hydroxyethylidene)amino]-3-(3h-imidazol-4-yl)propanoic acid

C8H12N4O3 (212.0909)

(4s)-4-amino-4-{[(1s)-1-carboxy-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C14H18N2O6 (310.1165)

(3s)-3-amino-3-{[(1s)-1-carboxy-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}propanoic acid

C13H16N2O6 (296.1008)

3-benzyl-1-hydroxy-3h,6h,7h,8h,9h,9ah-pyrido[1,2-a]pyrazin-4-one

C15H18N2O2 (258.1368)

1-hydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-8-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁴,⁹.0¹⁴,²².0¹⁶,²⁰]tricosa-2,4(9),5,10-tetraene-15,21-dione

C26H31N3O4 (449.2314)

(2s)-2-[(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

C14H19N3O5 (309.1325)

2-[(4-bromo-1h-pyrrol-2-yl)formamido]-6-carbamimidamidohexanoic acid

C12H18BrN5O3 (359.0593)

(2s)-2-amino-n-[(2s)-1-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(1h-indol-3-yl)propanoyl]oxy}-3-(1h-indol-3-yl)-1-oxopropan-2-yl]propanimidic acid

C28H32N6O5 (532.2434)

7-hydroxy-11-(hydroxymethyl)-17-methyl-12,13,14,15-tetrathia-9,17-diazatetracyclo[9.4.2.0¹,⁹.0³,⁸]heptadeca-3,5-diene-10,16-dione

C13H14N2O4S4 (389.9836)

1-hydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-6-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]tricosa-2(11),3,5(10),8-tetraene-15,21-dione

C26H31N3O4 (449.2314)

2-amino-4-{[1-carboxy-2-(3h-imidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C11H16N4O5 (284.1121)

(1r,4s,7r,9r)-16-acetyl-6-hydroxy-4-(2-methylpropyl)-3-oxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-9-yl acetate

C21H25N3O5 (399.1794)

(2s)-2-amino-4-{[(1r)-2-(benzylsulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid

C15H20N2O5S (340.1093)

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C13H17N3O5 (295.1168)

(2r,3e)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-5-phosphonopent-3-enoic acid

C12H21N4O8P (380.1097)

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

C18H25N3O6 (379.1743)

3-({5-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1,2,3,4,6-pentahydroxyhexylidene}amino)-3-phenylpropanoic acid

C21H33N3O8 (455.2268)

2-{2-[(1,4-dihydroxy-2-{[hydroxy(phenyl)methylidene]amino}butylidene)amino]-n-methylpropanamido}-4-methylpentanoic acid

C21H31N3O6 (421.2213)

(2s)-2-{[(2s)-2,6-diamino-1-hydroxyhexylidene]amino}-3-methylbutanoic acid

C11H23N3O3 (245.1739)

2-[(1-hydroxy-2-{[hydroxy((3,4,5-trihydroxy-6-methyloxan-2-yl)oxy)phosphoryl]amino}-4-methylpentylidene)amino]-3-(1h-indol-3-yl)propanoic acid

C23H34N3O10P (543.1982)

(2s)-2-[(1-hydroxyethylidene)amino]-3-(3h-imidazol-4-yl)propanoic acid

C8H11N3O3 (197.08)

11-(hydroxymethyl)-12-methyl-10,13-dioxo-14-thia-9,12-diazatetracyclo[9.2.1.0¹,⁹.0³,⁸]tetradeca-3,5-dien-7-yl acetate

C15H16N2O5S (336.078)

5-carbamimidamido-2-[2-(6-hydroxy-1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

C16H19N5O5 (361.1386)

2-({2-[(2-amino-1-hydroxy-3-phenylpropylidene)amino]-1-hydroxypropylidene}amino)-3-(1h-indol-3-yl)propanoic acid

C23H26N4O4 (422.1954)

(3s,8as)-3-[(3,4-dihydroxyphenyl)methyl]-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C14H16N2O4 (276.111)

methyl (2s)-2-(carbamoylformamido)-4-methylpentanoate

C9H16N2O4 (216.111)

(2s)-2-[(3-amino-1-hydroxypropylidene)amino]-3-(3h-imidazol-4-yl)propanoic acid

C9H14N4O3 (226.1066)

(2r)-2-[(2s,3r)-2-[(1-hydroxyethylidene)amino]-n,3-dimethylpentanamido]-3-phenylpropanoic acid

C18H26N2O4 (334.1892)

(2s)-2-[(2r)-2-{[(2s)-1,4-dihydroxy-2-{[hydroxy(phenyl)methylidene]amino}butylidene]amino}-n-methylpropanamido]-4-methylpentanoic acid

C21H31N3O6 (421.2213)

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C34H38N6O7 (642.2802)